Long-lasting complete responses in patients with metastatic melanoma after adoptive cell therapy with tumor-infiltrating lymphocytes and an attenuated IL2 regimen R Andersen, M Donia, E Ellebaek, TH Borch, P Kongsted, TZ Iversen, ... Clinical cancer research 22 (15), 3734-3745, 2016 | 344 | 2016 |
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters L Engell-Noerregaard, TH Hansen, MH Andersen, P thor Straten, ... Cancer immunology, immunotherapy 58, 1-14, 2009 | 269 | 2009 |
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study P Kongsted, TH Borch, E Ellebaek, TZ Iversen, R Andersen, Ö Met, ... Cytotherapy 19 (4), 500-513, 2017 | 70 | 2017 |
Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies TH Borch, M Donia, MH Andersen, IM Svane Drug discovery today 20 (9), 1127-1134, 2015 | 53 | 2015 |
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine S Munir Ahmad, E Martinenaite, M Hansen, N Junker, TH Borch, Ö Met, ... Oncoimmunology 5 (8), e1202391, 2016 | 41 | 2016 |
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma TH Borch, L Engell-Noerregaard, T Zeeberg Iversen, E Ellebaek, Ö Met, ... Oncoimmunology 5 (9), e1207842, 2016 | 37 | 2016 |
PD-L1-specific T cells SM Ahmad, TH Borch, M Hansen, MH Andersen Cancer immunology, immunotherapy 65, 797-804, 2016 | 26 | 2016 |
Influence of metronomic cyclophosphamide and interleukin-2 alone or combined on blood regulatory T-cells in patients with advanced malignant melanoma treated with dendritic … L Engell-Noerregaard, E Ellebaek, TZ Iversen, TH Hansen, MK Brimnes, ... J Clin Cell Immunol 3 (118), 2, 2012 | 8 | 2012 |
Immune monitoring using mRNA-transfected dendritic cells TH Borch, IM Svane, Ö Met Synthetic mRNA: Production, Introduction Into Cells, and Physiological …, 2016 | 2 | 2016 |